Significance Vaccines are required to control COVID-19 during the current pandemic and possibly afterward. Recombinant nucleic acids, proteins, and virus vectors that stimulate immune responses to the SARS-CoV-2 S protein have provided protection in experimental animal and human clinical trials, although questions remain regarding their ability to prevent spread and the duration of immunity. The present study focuses on replication-restricted modified vaccinia virus Ankara (MVA), which has been shown to be a safe, immunogenic, and stable smallpox vaccine and a promising vaccine vector for other infectious diseases and cancer. In a transgenic mouse model, one or two injections of recombinant MVAs that express modified forms of S inhibited SARS-CoV-2 replication in the upper and lower respiratory tracts and prevented severe disease. Modified vaccinia virus Ankara (MVA) is a replication-restricted smallpox vaccine, and numerous clinical studies of recombinant MVAs (rMVAs) as vectors for prevention of other infectious diseases, including COVID-19, are in progress. Here, we characterize rMVAs expressing the S protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Modifications of full-length S individually or in combination included two proline substitutions, mutations of the furin recognition site, and deletion of the endoplasmic retrieval signal. Another rMVA in which the receptor binding domain (RBD) is flanked by the signal peptide and transmembrane domains of S was also constructed. Each modified S protein was displayed on the surface of rMVA-infected cells and was recognized by anti-RBD antibody and soluble hACE2 receptor. Intramuscular injection of mice with the rMVAs induced antibodies, which neutralized a pseudovirus in vitro and, upon passive transfer, protected hACE2 transgenic mice from lethal infection with SARS-CoV-2, as well as S-specific CD3+CD8+IFNγ+ T cells. Antibody boosting occurred following a second rMVA or adjuvanted purified RBD protein. Immunity conferred by a single vaccination of hACE2 mice prevented morbidity and weight loss upon intranasal infection with SARS-CoV-2 3 wk or 7 wk later. One or two rMVA vaccinations also prevented detection of infectious SARS-CoV-2 and subgenomic viral mRNAs in the lungs and greatly reduced induction of cytokine and chemokine mRNAs. A low amount of virus was found in the nasal turbinates of only one of eight rMVA-vaccinated mice on day 2 and none later. Detection of low levels of subgenomic mRNAs in turbinates indicated that replication was aborted in immunized animals.
【저자키워드】 COVID-19, neutralizing antibody, coronavirus vaccine, modified vaccinia virus Ankara, transgenic mouse model, 【초록키워드】 antibodies, SARS-CoV-2, Vaccine, coronavirus, immune response, vaccination, pandemic, Mutation, Infectious diseases, Diseases, Immunity, S protein, furin, antibody, T cells, Cancer, peptide, lung, detection, cytokine, Proteins, Infectious disease, in vitro, severe acute respiratory syndrome Coronavirus, virus, chemokine, hACE2, Receptor binding domain, Replication, Spread, Protein, Viral, nucleic acids, pseudovirus, mice, RBD, vector, immune responses, Lungs, morbidity, Deletion, modified vaccinia virus Ankara, respiratory, SARS-CoV-2 replication, intranasal, SARS-CoV-2 S protein, clinical study, Combination, mRNAs, subgenomic mRNA, recombinant, severe disease, Lower respiratory tract, anti-RBD, Safe, Intramuscular injection, nasal turbinate, signal peptide, nasal turbinates, other infectious diseases, passive transfer, smallpox vaccine, weight loss, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, infected cells, subgenomic mRNAs, IFNγ, transgenic mice, transfer, injection, human clinical trials, hACE2 receptor, proline, immunogenic, upper and lower respiratory tracts, modifications, Express, vectors, transmembrane domain, modified vaccinia virus, full-length S, lethal infection, single vaccination, subgenomic viral mRNAs, transmembrane domains, Prevent, Cell, Transgenic mouse, immunized, Virus vector, neutralized, shown, occurred, indicated, required, inhibited, form, eight, provided, reduced, question, the S protein, prevented, expressing, stimulate, infection with SARS-CoV-2, proline substitutions, purified RBD, Significance, subgenomic viral mRNA, the SARS-CoV-2, the signal peptide, vaccinia virus Ankara, 【제목키워드】 SARS-CoV-2, Vaccine, Infection, respiratory, Lower respiratory tract, transgenic mice, injection,